Given the clinical course of youth-onset T2D and limited treatment options (metformin, insulin or subcutaneous GLP-1 agonist), there is an increasing need for interventions that not only improve glycemic control and reduce insulin resistance, but also promote behavioral modifications such as exercise and healthy eating. Here, INS is linked to type 2 diabetes mellitus.